Effective Use of a Glucagon-Like Peptide-1 Drug in a Patient with Repeated Pancreatitis Caused by High Triglycerides

A GLP-1 receptor agonist was associated with weight loss, lower triglycerides, and no recurrent pancreatitis in one patient with recurrent hypertriglyceridemia-induced pancreatitis.

This single case report describes a 42-year-old woman with recurrent HTG-induced acute pancreatitis who achieved 15% weight loss, sustained triglyceride reduction, and remained AP-free while on GLP-1RA therapy.

The evidence is limited to one patient, so it cannot resolve broader safety concerns about GLP-1RAs in people with prior pancreatitis.